Capillary leakage in post-cardiac arrest survivors during therapeutic hypothermia - a prospective, randomised study.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine · 2010-05-25 · Randomised trial
Abstract
BACKGROUND: Fluids are often given liberally after the return of spontaneous circulation. However, the optimal fluid regimen in survivors of cardiac arrest is unknown. Recent studies indicate an increased fluid requirement in post-cardiac arrest patients. During hypothermia, animal studies report extravasation in several organs, including the brain. We investigated two fluid strategies to determine whether the choice of fluid would influence fluid requirements, capillary leakage and oedema formation. METHODS: 19 survivors with witnessed cardiac arrest of primary cardiac origin were allocated to either 7.2% hypertonic saline with 6% poly (O-2-hydroxyethyl) starch solution (HH) or standard fluid therapy (Ringer's Acetate and saline 9 mg/ml) (control). The patients were treated with the randomised fluid immediately after admission and continued for 24 hours of therapeutic hypothermia. RESULTS: During the first 24 hours, the HH patients required significantly less i.v. fluid than the control patients (4750 ml versus 8010 ml, p = 0.019) with comparable use of vasopressors. Systemic vascular resistance was significantly reduced from 0 to 24 hours (p = 0.014), with no difference between the groups. Colloid osmotic pressure (COP) in serum and interstitial fluid (p < 0.001 and p = 0.014 respectively) decreased as a function of time in both groups, with a more pronounced reduction in interstitial COP in the crystalloid group. Magnetic resonance imaging of the brain did not reveal vasogenic oedema. CONCLUSIONS: Post-cardiac arrest patients have high fluid requirements during therapeutic hypothermia, probably due to increased extravasation. The use of HH reduced the fluid requirement significantly. However, the lack of brain oedema in both groups suggests no superior fluid regimen. Cardiac index was significantly improved in the group treated with crystalloids. Although we do not associate HH with the renal failures that developed, caution should be taken when using hypertonic starch solutions in these patients. TRIAL REGISTRATION: NCT00347477.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Crystalloids · Fluids & blood · Hypertonic saline · Temperature management
Related articles
- Induction of Therapeutic Hypothermia During Out-of-Hospital Cardiac Arrest Using a Rapid Infusion of Cold Saline: The RINSE Trial (Rapid Infusion of Cold Normal Saline). (Circulation, 2016)
- Effect of prehospital initiation of therapeutic hypothermia in adults with cardiac arrest on time-to-target temperature. (CJEM, 2015)
- Impact of intra-arrest therapeutic hypothermia in outcomes of prehospital cardiac arrest: a randomized controlled trial. (Intensive Care Med, 2014)
- Feasibility study of immediate pharyngeal cooling initiation in cardiac arrest patients after arrival at the emergency room. (Resuscitation, 2014)
- Induction of prehospital therapeutic hypothermia after resuscitation from nonventricular fibrillation cardiac arrest*. (Crit Care Med, 2012)
- Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest: a randomized controlled trial. (Circulation, 2010)